Pharmaceutical CDMO Services -Global Market Status and Trend Report 2013-2023
Table of Contents
Chapter 1 Overview of Pharmaceutical CDMO Services
- 1.1 Definition of Pharmaceutical CDMO Services in This Report
- 1.2 Commercial Types of Pharmaceutical CDMO Services
- 1.2.1 Drug Substance Development and Manufacturing
- 1.2.2 Specialized Services
- 1.2.3 Lab-based Services
- 1.3 Downstream Application of Pharmaceutical CDMO Services
- 1.3.1 nnovative Medicine
- 1.3.2 Patented Drug
- 1.3.3 Patent Expired Drug
- 1.4 Development History of Pharmaceutical CDMO Services
- 1.5 Market Status and Trend of Pharmaceutical CDMO Services 2013-2023
- 1.5.1 Global Pharmaceutical CDMO Services Market Status and Trend 2013-2023
- 1.5.2 Regional Pharmaceutical CDMO Services Market Status and Trend 2013-2023
Chapter 2 Global Market Status and Forecast by Regions
- 2.1 Market Development of Pharmaceutical CDMO Services 2013-2017
- 2.2 Production Market of Pharmaceutical CDMO Services by Regions
- 2.2.1 Production Volume of Pharmaceutical CDMO Services by Regions
- 2.2.2 Production Value of Pharmaceutical CDMO Services by Regions
- 2.3 Demand Market of Pharmaceutical CDMO Services by Regions
- 2.4 Production and Demand Status of Pharmaceutical CDMO Services by Regions
- 2.4.1 Production and Demand Status of Pharmaceutical CDMO Services by Regions 2013-2017
- 2.4.2 Import and Export Status of Pharmaceutical CDMO Services by Regions 2013-2017
Chapter 3 Global Market Status and Forecast by Types
- 3.1 Production Volume of Pharmaceutical CDMO Services by Types
- 3.2 Production Value of Pharmaceutical CDMO Services by Types
- 3.3 Market Forecast of Pharmaceutical CDMO Services by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
- 4.1 Demand Volume of Pharmaceutical CDMO Services by Downstream Industry
- 4.2 Market Forecast of Pharmaceutical CDMO Services by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Pharmaceutical CDMO Services
- 5.1 Global Economy Situation and Trend Overview
- 5.2 Pharmaceutical CDMO Services Downstream Industry Situation and Trend Overview
Chapter 6 Pharmaceutical CDMO Services Market Competition Status by Major Manufacturers
- 6.1 Production Volume of Pharmaceutical CDMO Services by Major Manufacturers
- 6.2 Production Value of Pharmaceutical CDMO Services by Major Manufacturers
- 6.3 Basic Information of Pharmaceutical CDMO Services by Major Manufacturers
- 6.3.1 Headquarters Location and Established Time of Pharmaceutical CDMO Services Major Manufacturer
- 6.3.2 Employees and Revenue Level of Pharmaceutical CDMO Services Major Manufacturer
- 6.4 Market Competition News and Trend
- 6.4.1 Merger, Consolidation or Acquisition News
- 6.4.2 Investment or Disinvestment News
- 6.4.3 New Product Development and Launch
Chapter 7 Pharmaceutical CDMO Services Major Manufacturers Introduction and Market Data
- 7.1 WuXi AppTec Group
- 7.1.1 Company profile
- 7.1.2 Representative Pharmaceutical CDMO Services Product
- 7.1.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of WuXi AppTec Group
- 7.2 Strides Pharma Science Limited
- 7.2.1 Company profile
- 7.2.2 Representative Pharmaceutical CDMO Services Product
- 7.2.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Strides Pharma Science Limited
- 7.3 Aenova Group
- 7.3.1 Company profile
- 7.3.2 Representative Pharmaceutical CDMO Services Product
- 7.3.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Aenova Group
- 7.4 AMRI Global
- 7.4.1 Company profile
- 7.4.2 Representative Pharmaceutical CDMO Services Product
- 7.4.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of AMRI Global
- 7.5 Recipharm AB
- 7.5.1 Company profile
- 7.5.2 Representative Pharmaceutical CDMO Services Product
- 7.5.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Recipharm AB
- 7.6 Patheon N.V.
- 7.6.1 Company profile
- 7.6.2 Representative Pharmaceutical CDMO Services Product
- 7.6.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Patheon N.V.
- 7.7 Siegfried Ltd
- 7.7.1 Company profile
- 7.7.2 Representative Pharmaceutical CDMO Services Product
- 7.7.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Siegfried Ltd
- 7.8 Amatsigroup
- 7.8.1 Company profile
- 7.8.2 Representative Pharmaceutical CDMO Services Product
- 7.8.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Amatsigroup
- 7.9 Catalent, Inc.
- 7.9.1 Company profile
- 7.9.2 Representative Pharmaceutical CDMO Services Product
- 7.9.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Catalent, Inc.
- 7.10 Piramal Pharma Solutions
- 7.10.1 Company profile
- 7.10.2 Representative Pharmaceutical CDMO Services Product
- 7.10.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Piramal Pharma Solutions
- 7.11 Fareva Group
- 7.11.1 Company profile
- 7.11.2 Representative Pharmaceutical CDMO Services Product
- 7.11.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Fareva Group
- 7.12 FAMAR Health Care Services
- 7.12.1 Company profile
- 7.12.2 Representative Pharmaceutical CDMO Services Product
- 7.12.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of FAMAR Health Care Services
Chapter 8 Upstream and Downstream Market Analysis of Pharmaceutical CDMO Services
- 8.1 Industry Chain of Pharmaceutical CDMO Services
- 8.2 Upstream Market and Representative Companies Analysis
- 8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Pharmaceutical CDMO Services
- 9.1 Cost Structure Analysis of Pharmaceutical CDMO Services
- 9.2 Raw Materials Cost Analysis of Pharmaceutical CDMO Services
- 9.3 Labor Cost Analysis of Pharmaceutical CDMO Services
- 9.4 Manufacturing Expenses Analysis of Pharmaceutical CDMO Services
Chapter 10 Marketing Status Analysis of Pharmaceutical CDMO Services
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.1.3 Marketing Channel Development Trend
- 10.2 Market Positioning
- 10.2.1 Pricing Strategy
- 10.2.2 Brand Strategy
- 10.2.3 Target Client
- 10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
- 12.1 Methodology/Research Approach
- 12.1.1 Research Programs/Design
- 12.1.2 Market Size Estimation
- 12.1.3 Market Breakdown and Data Triangulation
- 12.2 Data Source
- 12.2.1 Secondary Sources
- 12.2.2 Primary Sources
Report Summary
Pharmaceutical CDMO Services -Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pharmaceutical CDMO Services industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Pharmaceutical CDMO Services 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Pharmaceutical CDMO Services worldwide, with company and product introduction, position in the Pharmaceutical CDMO Services market
Market status and development trend of Pharmaceutical CDMO Services by types and applications
Cost and profit status of Pharmaceutical CDMO Services , and marketing status
Market growth drivers and challenges
The report segments the global Pharmaceutical CDMO Services market as:
Global Pharmaceutical CDMO Services Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Pharmaceutical CDMO Services Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Drug Substance Development and Manufacturing
Specialized Services
Lab-based Services
Global Pharmaceutical CDMO Services Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
nnovative Medicine
Patented Drug
Patent Expired Drug
Global Pharmaceutical CDMO Services Market: Manufacturers Segment Analysis (Company and Product introduction, Pharmaceutical CDMO Services Sales Volume, Revenue, Price and Gross Margin):
WuXi AppTec Group
Strides Pharma Science Limited
Aenova Group
AMRI Global
Recipharm AB
Patheon N.V.
Siegfried Ltd
Amatsigroup
Catalent, Inc.
Piramal Pharma Solutions
Fareva Group
FAMAR Health Care Services
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.